Tumour radiomics has also recently emerged as a tool to predict adult high-grade glioma subtypes, showing the ability to classify gliomas into two distinct molecular subgroups, IDH-wildtype and IDH-mutant, in patients [13]. This evidence concerns the gene IDH1 and glioma.